Back to Search
Start Over
Supplementary Materials from A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Contains supplementary tables and methods
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....355b3c9ba3ae1a5cd1e94863c31b57cd
- Full Text :
- https://doi.org/10.1158/1078-0432.22468854.v1